(Q35565841)

8 August 2017

1 reference

title

Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment, and prognosis (English)

1 reference

anaplastic oligodendroglioma

8 August 2017

1 reference

1 reference

inferred from title

adult oligodendroglioma

1 reference

Herbert H Engelhard

1

1 reference

8 August 2017

Ana Stelea

series ordinal

2

1 reference

8 August 2017

Arno Mundt

series ordinal

3

1 reference

8 August 2017

publication date

1 November 2003

1 reference

8 August 2017

1 reference

8 August 2017

volume

60

1 reference

8 August 2017

issue

5

1 reference

8 August 2017

page(s)

443-456

1 reference

Oligodendroglioma: an analysis of prognostic factors and treatment results

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Radiation and chemotherapy improve outcome in oligodendroglioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Primary intrinsic brainstem oligodendroglioma in an adult. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Low grade gliomas: functional mapping resection strategies, extent of resection, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Chemotherapy for aggressive or anaplastic high grade oligodendrogliomas and oligoastrocytomas: better than a salvage treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Prognostic factors in children and adolescents with low-grade oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Cerebral oligodendroglioma: prognostic factors and life history.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Salvage chemotherapy with paclitaxel for recurrent oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Oligodendrogliomas. I. A clinical study of cerebral oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Chemotherapy for the treatment of oligodendroglial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Multiple oligodendroglioma: case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Non-invasive grading of oligodendrogliomas: correlation between in vivo metabolic pattern and histopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

PCV chemotherapy for oligodendroglioma: response analyzed on T2 weighted-MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Transcriptional inactivation of TP73 expression in oligodendroglial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Oligodendroglioma: pathology and molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Descriptive epidemiology of cerebral gliomas in France.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Treatment of adults with progressive oligodendroglioma with carboplatin (CBDCA): preliminary results. Writing Committee for The Brain Tumor Center at Duke

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

The role of postoperative irradiation in the treatment of oligodendroglioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Primary oligodendroglioma of the septum pellucidum

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Oligodendrogliomas of the fourth ventricle: report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Randomized trials of radiation therapy in adult low-grade gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Molecular heterogeneity of oligodendrogliomas suggests alternative pathways in tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Advances in diagnosis and management of oligodendroglioma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma. A phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Combined treatment modality for anaplastic oligodendroglioma: a phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Oligodendroglioma: the Rotterdam-Dijkzigt experience

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Magnetic resonance features of the enigmatic oligodendroglioma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Intracranial oligodendrogliomas: imaging findings in 35 untreated cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Oligodendrogliomas in the CT/MR-era.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Controversies in the treatment of low-grade astrocytomas and oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Seizure disorders in patients with brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

The pathways of extraneural spread in metastasizing gliomas: a report of three cases and critical review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

A clinicopathological study of 323 patients with oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Retinal oligodendroglioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Low-grade oligodendroglioma responds to chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Blood flow and metabolism of oligodendrogliomas: a positron emission tomography study with kinetic analysis of 18F-fluorodeoxyglucose

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Oligodendroglioma: incidence and biological behavior in a defined population

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Long-term outcome of low-grade oligodendroglioma and mixed glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

1 reference

7 January 2021

Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Current treatment of oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Salvage chemotherapy for oligodendroglioma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Observations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheres

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Pediatric oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

[Oligodendroglioma: a pathological and clinical study of 15 cases]

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Primary leptomeningeal oligodendroglioma: case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Supratentorial astrocytomas and oligodendrogliomas treated in the MRI era

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Intradural drop metastases in oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Oligodendrogliomas: the Mayo Clinic experience

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Management of oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Investigating development of infective stage larvae of filarial nematodes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Factors possibly influencing the prognosis of oligodendroglioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Enhanced accuracy in differential diagnosis of radiation necrosis by positron emission tomography-magnetic resonance imaging coregistration: technical case report.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

New perspectives for the diagnosis and treatment of oligodendroglioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Temozolomide chemotherapy in recurrent oligodendroglioma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Prognostic significance of the endothelial surface in low-grade resected oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Reirradiation of primary brain tumours: survival, clinical response and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Recurrent oligodendroglioma diagnosed with 11C-L-methionine and PET: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Clinicopathological study of oligodendroglial tumors: the effectiveness of interferon beta, ACNU/MCNU, and radiation (IAR/IMR) for anaplastic tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Treatment of oligodendrogliomas with or without postoperative irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Prognostic factors in oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendroglioma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

PCV for oligodendroglial tumors: in search of prognostic factors for response and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0090-3019%2803%2900167-8

7 January 2021

10.1016/S0090-3019(03)00167-8

Identifiers

DOI

1 reference

8 August 2017

1 reference